|
231 |
L. reuteri in Supportive Periodontal Therapy—Are There Already Clinical Effects after 3 Months with One Lozenge a Day? A Double-Blind Randomized Placebo-Controlled Study
Thierbach, René. - Saarbrücken : Saarländische Universitäts- und Landesbibliothek, 2024
|
|
|
|
232 |
Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials
Quattrone, Andrea. - Ludwig-Maximilians-Universität München, 2024
|
|
|
|
233 |
Oxytocin and social learning in socially anxious men and women
Flechsenhar, Aleyna. - Ludwig-Maximilians-Universität München, 2024
|
|
|
|
234 |
Peripheral Blood Leukocyte Subpopulation Changes in Reaction to an Acute Psychosocial Stressor as Compared to an Active Placebo-Stressor in Healthy Young Males : Mediating Effects of Major Stress-Reactive Endocrine Parameters
Walther, Lisa-Marie. - Konstanz : KOPS Universität Konstanz, 2024
|
|
|
|
235 |
Protein Supplementation Increases Adaptations to Low-Volume, Intra-Session Concurrent Training in Untrained Healthy Adults: A Double-Blind, Placebo-Controlled, Randomized Trial
Reljic, Dejan. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2024
|
|
|
|
236 |
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD)
Wolff, Andreas W.. - Ludwig-Maximilians-Universität München, 2024
|
|
|
|
237 |
Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study
Bavendiek, Udo. - Würzburg : Universität Würzburg, 2024
|
|
|
|
238 |
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Behrens, Frank. - Würzburg : Universität Würzburg, 2024
|
|
|
|
239 |
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS)
Koch, Jan Christoph. - Ludwig-Maximilians-Universität München, 2024
|
|
|
|
240 |
Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers
Möller, Hans-Jürgen. - Würzburg : Universität Würzburg, 2024
|
|
Administration
